補聴器市場調査レポート：製品別（補聴器、インプラント）、難聴タイプ別（感音性難聴、伝音性難聴）、患者タイプ別（成人、小児）、技術別（デジタル、アナログ） 2032年までの予測
Hearing Aids Market Research Report By Product (Hearing aid devices and Hearing implants), By Type of Hear Loss (Sensorineural hearing loss and Conductive hearing loss), By Patient Type (Adults and Pediatrics), By Technology (Digital and Analog) Forecast to 2032
補聴器市場調査レポート：製品別（補聴器、インプラント）、難聴タイプ別（感音性難聴、伝音性難聴）、患者タイプ別（成人、小児）、技術別（デジタル、アナログ） 2032年までの予測
市場概要
MRFRの分析による... もっと見る
サマリー 補聴器市場調査レポート：製品別（補聴器、インプラント）、難聴タイプ別（感音性難聴、伝音性難聴）、患者タイプ別（成人、小児）、技術別（デジタル、アナログ） 2032年までの予測
市場概要
MRFRの分析によると、補聴器市場規模は2023年に120億3,401万米ドルに達すると予測されている。補聴器市場は予測期間（2025-2032年）に約8.52％の複合年間成長率（CAGR）で進むと予測されている。
補聴器の世界市場が急速に拡大している背景には、いくつかの基本的な変数がある。このトレンドの主な原因の1つは、特に高齢者における難聴の有病率の増加である。世界中の政府や保健機関が聴覚の健康問題に対する認識を高めた結果、需要が増加している。さらに、デジタル補聴器の開発やワイヤレスネットワーク機能などの技術的進歩により、製品提供の拡大や顧客層の拡大が促進されている。さまざまな分野で消費者の可処分所得が増加しているため、生活の質を高める補聴器を利用できる個人の数は増えるだろう。さらに、補聴器の購入手続きも簡素化されるであろう。
市場区分
補聴器の世界市場を構成する製品セグメントは、聴覚インプラントと補聴器である。
難聴の形態に基づいて、世界市場は感音性難聴と伝音性難聴の2つのセグメントに分けられる。
また、患者のカテゴリーに基づくと、市場は成人と小児科の2つのセグメントに分けられる。
技術面では、補聴器の世界市場はアナログとデジタルに分けられる。
技術的には、市場はデジタルとアナログの2つのセグメントに分けられる。
エンドユーザー市場は3つのセグメントに分けられる：メディケア／メディケイド、第三者支払機関、個人支払／自費。
地域の視点
本調査では、以下の地域の補聴器市場情報を提供している：北米、ヨーロッパ、アジア太平洋地域、その他の地域である。2023年の世界市場では北米が圧倒的な強さを見せた。補聴器の販売台数の増加、美観を重視した目立たない補聴器の普及、新製品の投入など、いくつかの要因が予測期間中の北米の最大成長率に寄与すると予測されている。欧州は、政府による実質的な支援と最先端の補聴器開発のための研究拡大により、第2位のシェアを占めると予想されている。この地域には、GN Store Nord A/S、Senovo、Demant A/S、WS Audiologyなど複数の企業が戦略的に進出していることも成長に寄与すると予想される。National Institute for Health and Care Excellence (NICE)によると、現在イギリスでは毎年約1,260人が人工内耳の治療を受けている。さらに、市場の拡大を促すだろう。人口の高齢化と人工内耳の使用の増加は、予測期間中にアジア太平洋地域で最も高い複合年間成長率（CAGR）をもたらすと予想されている。Hear-it.orgによると、オーストラリアの難聴者数は36億人と推定されている。この数字は2060年までに78億人に増加すると予想されており、国の経済発展に寄与すると期待されている。
主要プレーヤー
補聴器市場の主要プレーヤーには、Starkey Hearing Technologies、Signia、Oticon、Demant、GN Store Nord、Unitron、Eargo、Cochlear、WS Audiology、Rexton、MED-EL (Medical Electronics)、William Demant Holding A/S、Amplifon、Sonova、Audina Hearing Instruments、Beltone、Hearing Lifeなどがある。
ページTOPに戻る
目次 目次
2.
2.
2.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
4.
4.
4.
4.
4.
4.
4.
4.
4.
4.
5.
5.
5.
5.
5.
5.
5.
5.
5.
5.
6.
6.
6.
6.
6.
6.
6.
6.
6.
6.
7.
7.
7.
8.
8.
8.
9.
9.
9.
10.
10.
10.
10.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
11.
12.
12.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
13.
ページTOPに戻る
Summary Hearing Aids Market Research Report By Product (Hearing aid devices and Hearing implants), By Type of Hear Loss (Sensorineural hearing loss and Conductive hearing loss), By Patient Type (Adults and Pediatrics), By Technology (Digital and Analog) Forecast to 2032
Market Overview
According to the MRFR analysis, the hearing aids market size was anticipated to reach USD 12,034.01 million in 2023. The hearing devices market is expected to advance at a compound annual growth rate (CAGR) of approximately 8.52% during the forecast period (2025–2032).
The global market for hearing aids is expanding swiftly because of a number of fundamental variables. One of the primary causes of this trend is the increasing prevalence of hearing loss, particularly among the elderly. The demand is increasing as a result of the increased awareness of auditory health issues by governments and health organizations worldwide. Furthermore, the expansion of product offerings and the expansion of the clientele have been facilitated by technological advancements such as the development of digital hearing aides and wireless networking capabilities. The increasing disposable income of consumers in a variety of sectors will result in a greater number of individuals having access to hearing aids that can enhance their quality of life. Additionally, the process of purchasing these devices will be simplified.
Market Segmentation
Hearing implants and hearing aid devices are the two product segments that comprise the global market for hearing aids.
Based on the form of hearing loss, the global market is divided into two segments: sensorineural and conductive.
The market is divided into two segments based on the category of patient: adults and pediatrics.
Technology-wise, the global market for hearing aides is divided between analog and digital.
Technology divides the market into two segments: digital and analog.
The end-user market is divided into three segments: Medicare/Medicaid, third-party payer, and private pay/out-of-pocket.
Local Perspectives
The study provides market information for hearing aids in the following regions: North America, Europe, Asia-Pacific, and the rest of the globe. North America was the dominant force in the global market in 2023. Several factors, such as the increasing sales volume of hearing devices, the widespread adoption of less noticeable devices for greater aesthetic appeal, and the introduction of new products, are expected to contribute to North America's maximum growth rate during the forecast period. Europe is anticipated to possess the second-largest share as a result of the substantial government support and the expansion of research into the development of state-of-the-art hearing apparatus. The strategic presence of several businesses in the region, such as GN Store Nord A/S, Senovo, Demant A/S, and WS Audiology, is also expected to contribute to growth. According to the National Institute for Health and Care Excellence (NICE), approximately 1,260 individuals in England currently receive cochlear implants each year. Furthermore, it would encourage market expansion. The aging population and the increasing use of hearing implants are expected to result in the highest compound annual growth rate (CAGR) in Asia Pacific during the projection period. According to Hear-it.org, the number of Australians with hearing loss is estimated to be 3.6 billion. This figure is expected to increase to 7.8 billion by 2060, which is expected to contribute to the nation's economic development.
Primary Players
Some of the major players in the hearing aids market include Starkey Hearing Technologies, Signia, Oticon, Demant, GN Store Nord, Unitron, Eargo, Cochlear, WS Audiology, Rexton, MED-EL (Medical Electronics), William Demant Holding A/S, Amplifon, Sonova, Audina Hearing Instruments, Beltone, and Hearing Life.
ページTOPに戻る
Table of Contents TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................................................................................... 18
2 MARKET INTRODUCTION ............................................................................................................ 20
2.1 DEFINITION .................................................................................................................................................................. 20
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 20
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 20
3 RESEARCH METHODOLOGY ...................................................................................................... 21
3.1 OVERVIEW .................................................................................................................................................................... 21
3.2 DATA FLOW .................................................................................................................................................................. 23
3.2.1 Data Mining Process ....................................................................................................................................... 23
3.3 PURCHASED DATABASE: ......................................................................................................................................... 24
3.4 SECONDARY SOURCES: ............................................................................................................................................ 25
3.4.1 Secondary Research data flow: ........................................................................................................................ 26
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 27
3.5.1 Primary Research DATA FLOW: ....................................................................................................................... 28
3.5.2 Primary Research: Number of Interviews conducted ........................................................................................ 29
3.5.3 Primary Research: Regional Coverage ............................................................................................................. 29
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 30
3.6.1 Revenue Analysis Approach ............................................................................................................................ 30
3.7 DATA FORECASTING................................................................................................................................................. 31
3.7.1 Data forecasting Type ..................................................................................................................................... 31
3.8 DATA MODELING ........................................................................................................................................................ 32
3.8.1 microeconomic factor analysis: ....................................................................................................................... 32
3.8.2 Data modeling: ............................................................................................................................................... 33
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 35
4 MARKET DYNAMICS .................................................................................................................... 37
4.1 INTRODUCTION ........................................................................................................................................................... 37
4.2 DRIVERS ......................................................................................................................................................................... 37
4.2.1 Increasing Incidences of Hearing Loss ............................................................................................................ 37
4.2.2 Growth of Elderly/Geriatric Population ............................................................................................................. 37
4.3 RESTRAINTS ................................................................................................................................................................ 37
4.3.1 High Cost and Affordability Issues ................................................................................................................... 37
4.3.2 Stigma and Social Acceptance ........................................................................................................................ 38
4.4 OPPORTUNITY ............................................................................................................................................................. 38
4.4.1 Rise in Disposable Income and Affordability..................................................................................................... 38
4.4.2 Technological Advancements .......................................................................................................................... 38
5 MARKET FACTOR ANALYSIS ...................................................................................................... 39
5.1 PORTER’S FIVE FORCES MODEL ........................................................................................................................... 39
5.1.1 Porter’s Five Forces Model .............................................................................................................................. 39
5.1.1.1 Threat of New Entrants ........................................................................................................................... 39
5.1.1.2 Bargaining Power of Suppliers ................................................................................................................ 40
5.1.1.3 Bargaining Power of Buyers .................................................................................................................... 40
5.1.1.4 Threat of Substitutes .............................................................................................................................. 40
5.1.1.5 Industry Rivalry ....................................................................................................................................... 41
5.2 IMPACT OF COVID-19 ON HEARING AIDS MARKET ....................................................................................... 41
5.3 OTC HEARING AID MARKET TRENDS ................................................................................................................ 41
5.4 PAYMENT MODE ANALYSIS BY REGION .......................................................................................................... 43
6 GLOBAL HEARING AIDS MARKET, BY PRODUCT ..................................................................... 48
6.1 INTRODUCTION ........................................................................................................................................................... 48
6.1.1 Hearing Aid Devices ........................................................................................................................................ 48
6.1.1.1 Behind-the-ear (BTE) Hearing Aids ........................................................................................................... 48
6.1.1.2 In-the-ear (ITE) Hearing Aids ................................................................................................................... 48
6.1.1.3 Canal Hearing Aids ................................................................................................................................. 48
6.1.1.4 Receiver-in-the-ear (RIE) Hearing Aid ....................................................................................................... 48
6.1.1.5 Others .................................................................................................................................................... 48
6.1.2 Hearing Implants ............................................................................................................................................ 48
6.1.2.1 Cochlear Implants .................................................................................................................................. 49
6.1.2.2 Bone-Anchored Hearing Aids (BAHA) ...................................................................................................... 49
7 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS ............................................ 51
7.1 INTRODUCTION ........................................................................................................................................................... 51
7.1.1 Sensorineural Hearing Loss............................................................................................................................. 51
7.1.2 Conductive Hearing Loss ................................................................................................................................ 51
8 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE .............................................................. 53
8.1 INTRODUCTION ........................................................................................................................................................... 53
8.1.1 Adults ............................................................................................................................................................ 53
8.1.2 Pediatrics ....................................................................................................................................................... 53
9 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY .............................................................. 55
9.1 INTRODUCTION ........................................................................................................................................................... 55
9.1.1 Digital ............................................................................................................................................................ 55
9.1.2 Analog ........................................................................................................................................................... 55
10 GLOBAL HEARING AIDS MARKET, BY END USER .................................................................... 57
10.1 INTRODUCTION ........................................................................................................................................................... 57
10.1.1 Private Pay/Out of Pocket ............................................................................................................................... 57
10.1.2 Third Party Payer ............................................................................................................................................ 57
10.1.3 Medicare/Medicaid ......................................................................................................................................... 57
11 GLOBAL HEARING AIDS MARKET, BY REGION ......................................................................... 59
11.1 INTRODUCTION ........................................................................................................................................................... 59
11.1.1 North America ................................................................................................................................................ 60
11.1.1.1 US ......................................................................................................................................................... 62
11.1.1.2 Canada .................................................................................................................................................. 64
11.1.1.3 Mexico .................................................................................................................................................. 65
11.1.2 EUROPE ......................................................................................................................................................... 67
11.1.2.1 Germany ................................................................................................................................................ 69
11.1.2.2 UK ......................................................................................................................................................... 71
11.1.2.3 France ................................................................................................................................................... 72
11.1.2.4 Italy ....................................................................................................................................................... 74
11.1.2.5 Spain ..................................................................................................................................................... 76
11.1.2.6 Rest Of Europe ....................................................................................................................................... 77
11.1.3 ASIA-PACIFIC ................................................................................................................................................. 79
11.1.3.1 Japan .................................................................................................................................................... 81
11.1.3.2 China ..................................................................................................................................................... 83
11.1.3.3 India ...................................................................................................................................................... 84
11.1.3.4 Australia ................................................................................................................................................ 86
11.1.3.5 Rest Of Asia Pacific ................................................................................................................................ 88
11.1.4 SOUTH AMERICA ............................................................................................................................................ 89
11.1.4.1 Brazil ..................................................................................................................................................... 91
11.1.4.2 Colombia ............................................................................................................................................... 93
11.1.4.3 Rest of South America ............................................................................................................................ 95
11.1.5 Middle East & Africa ....................................................................................................................................... 97
11.1.5.1 South Africa ........................................................................................................................................... 99
11.1.5.2 GCC Countries ........................................................................................................................................ 101
11.1.5.3 Rest of Middle East and Africa ................................................................................................................ 103
12 COMPETITIVE LANDSCAPE ........................................................................................................ 105
12.1 INTRODUCTION ........................................................................................................................................................... 105
12.2 MARKET SHARE ANALYSIS, 2023 ....................................................................................................................... 105
13 COMPANY PROFILES .................................................................................................................. 106
13.1 COCHLEAR LIMITED .................................................................................................................................................. 106
13.1.1 COMPANY OVERVIEW ..................................................................................................................................... 106
13.1.2 PRODUCTS OFFERed....................................................................................................................................... 106
13.1.3 SWOT ANALYSIS ............................................................................................................................................ 107
13.1.4 Key Strategy ................................................................................................................................................... 107
13.2 GN HEARING A/S ........................................................................................................................................................ 108
13.2.1 COMPANY OVERVIEW ..................................................................................................................................... 108
13.2.2 PRODUCTS OFFERed....................................................................................................................................... 108
13.2.3 SWOT ANALYSIS ............................................................................................................................................ 109
13.2.4 Key Strategy ................................................................................................................................................... 110
13.3 SONOVA ......................................................................................................................................................................... 111
13.3.1 COMPANY OVERVIEW ..................................................................................................................................... 111
13.3.2 PRODUCTS OFFERed....................................................................................................................................... 112
13.3.3 SWOT ANALYSIS ............................................................................................................................................ 113
13.3.4 Key Strategy ................................................................................................................................................... 113
13.4 WILLIAM DEMANT HOLDING A/S ........................................................................................................................ 114
13.4.1 COMPANY OVERVIEW ..................................................................................................................................... 114
13.4.2 PRODUCTS OFFERed....................................................................................................................................... 115
13.4.3 SWOT ANALYSIS ............................................................................................................................................ 116
13.4.4 Key Strategy ................................................................................................................................................... 117
13.5 STARKEY ....................................................................................................................................................................... 118
13.5.1 COMPANY OVERVIEW ..................................................................................................................................... 118
13.5.2 PRODUCTS OFFERed....................................................................................................................................... 118
13.5.3 SWOT ANALYSIS ............................................................................................................................................ 120
13.5.4 Key Strategy ................................................................................................................................................... 120
13.6 PETROFAC ..................................................................................................................................................................... 121
13.6.1 COMPANY OVERVIEW ..................................................................................................................................... 121
13.6.2 PRODUCTS OFFERed....................................................................................................................................... 121
13.6.3 SWOT ANALYSIS ............................................................................................................................................ 122
13.6.4 Key Strategy ................................................................................................................................................... 122
13.7 HALLIBURTON............................................................................................................................................................. 123
13.7.1 COMPANY OVERVIEW ..................................................................................................................................... 123
13.7.2 PRODUCTS OFFERed....................................................................................................................................... 123
13.7.3 SWOT ANALYSIS ............................................................................................................................................ 124
13.7.4 Key Strategy ................................................................................................................................................... 124
13.8 ZOUNDS HEARING ...................................................................................................................................................... 125
13.8.1 COMPANY OVERVIEW ..................................................................................................................................... 125
13.8.2 PRODUCTS OFFERed....................................................................................................................................... 125
13.8.3 SWOT ANALYSIS ............................................................................................................................................ 126
13.8.4 Key Strategy ................................................................................................................................................... 127
13.9 AUDINA HEARING INSTRUMENTS...................................................................................................................... 127
13.9.1 COMPANY OVERVIEW ..................................................................................................................................... 127
13.9.2 PRODUCTS OFFERed....................................................................................................................................... 128
13.9.3 SWOT ANALYSIS ............................................................................................................................................ 128
13.9.4 Key Strategy ................................................................................................................................................... 129
13.10 AMPLIFON .................................................................................................................................................................... 130
13.10.1 COMPANY OVERVIEW ..................................................................................................................................... 130
13.10.2 PRODUCTS OFFERed....................................................................................................................................... 130
13.10.3 SWOT ANALYSIS ............................................................................................................................................ 130
13.10.4 Key Strategy ................................................................................................................................................... 131
14 DATA CITATIONS ......................................................................................................................... 132
ページTOPに戻る
Market Research Future社の 医療分野 での最新刊レポート
-
抗肥満薬市場調査レポート：治療タイプ別（セロトニン・ノルエピネフリン再取り込み阻害薬、選択的セロトニン2C受容体作動薬、ノルエピネフリン・ドパミン再取り込み阻害薬）、リパーゼ阻害薬、GLP-1受容体作動薬、併用薬、その他）、薬物タイプ別（処方薬、市販薬）、作用機序別（中枢性抗肥満薬、末梢性抗肥満薬）、投与経路別（経口、皮下）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、欧州、アジア太平洋、南米、中東、アフリカ） 2035年までの予測
-
ジェネリック医薬品市場調査レポート：適応症別（中枢神経系（CNS）、循環器、泌尿器、腫瘍、呼吸器、その他）、投与経路別（経口、局所、非経口、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、欧州、アジア太平洋地域、その他の地域） 2035年までの予測
-
多発性硬化症治療装置市場調査レポート：タイプ別[原発性進行性多発性硬化症（PPMS）、二次性進行性多発性硬化症（SPMS）、再発寛解型多発性硬化症（RRMS）、臨床的孤立症候群（CIS）]、治療装置別[電気刺激装置（機能的電気刺激（FES）、経皮的電気神経刺激（TENS）, 神経刺激装置（脊髄刺激（SCS）, 脳深部刺激（DBS））]、エンドユーザー別（病院＆クリニック, 外来手術センター）、地域別（北米, 欧州, アジア太平洋, 南米, 中東およびアフリカ）2032年までの予測
-
Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035
-
Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
-
アフリカの動物用医薬品市場レポート 動物種別（動物、コンパニオンアニマル）、製品別（医薬品、ワクチン、飼料添加物、衛生用品、診断薬）、流通チャネル別（小売薬局、Eコマース、その他）、地域別（エジプト、ナイジェリア、アルジェリア、チュニジア、リビア、ウガンダ、タンザニア、南スーダン、ケニア、エチオピア、アフリカのその他）の調査レポート情報 2032年までの予測
-
アルテスネート注射剤の世界市場調査レポート：純度別（アルテスネート0.99、アルテスネート0.98）、用途別（マラリア、重症マラリア、脳マラリア、合併症のないマラリア、その他の用途）、エンドユーザー別（病院、診療所、薬局、政府機関、非政府組織）、流通チャネル別（直販、流通業者および卸売業者、小売薬局、オンライン販売）、地域別（北米、欧州、APAC、南米、MEA）2032年までの予測
-
欧州液体クロマトグラフィー機器サービス市場2030年までの予測調査レポート
-
アーユルヴェーダ市場
-
アジア太平洋地域の血液病理学用バイオマーカー市場調査レポート情報：タイプ別（製品・サービス）、癌タイプ別（リンパ腫、白血病）、技術カテゴリー別（NGS、PCR、IHC、FISH、その他）、2032年までの地域別予測
よくあるご質問
Market Research Future社はどのような調査会社ですか?
マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。
下記分野については、分野毎に専... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
